Print This Page Email This Page
Joint Efforts Underway for Development of SARS Vaccine
University of Hong Kong, Guangzhou Medical College and Fudan University are making joint efforts to develop vaccines for severe acute respiratory syndrome (SARS), according to a press release from the University of Hong Kong on Monday.

An activated strain of SARS coronavirus is now ready for testing as a tentative vaccine to be tested in animals, said the press release.

Researchers affirmed that it is still too early to tell whether this experimental vaccine is safe or effective in human. Human testing will not be conducted soon.

The preliminary animal test result of the activated strain of SARS coronavirus as a tentative vaccine could be available in six months, researchers said.

(Xinhua News Agency May 27, 2003)

Related Stories
- SARS Cases on Chinese Mainland Decline Faster
- China Issues Regulations on Public Health Emergencies
- State Council Shields Rural People from SARS Costs
- Chinese President on SARS Control, Economic Development
- Chinese Government Offers Financial Relief in SARS Fight
- China Allocates 50 Million Yuan on Anti-SARS Measures
- Number of New SARS Cases Hits New Low on Chinese Mainland

Print This Page Email This Page
'Tomorrow Plan' Helps Disabled Orphans
First Chinese Volunteers Head for South America
East China City Suspends Controversial Chemical Project Amid Pollution Fears
Second-hand Smoke a 'Killer at Large'
Private Capital Flows to Developing Countries Hit New Record in 2006
Survey: Most of China's Disabled Not Financially Independent


Product Directory
China Search
 Country Search
Hot Buys